500 Shares in Aflac Incorporated (NYSE:AFL) Bought by Campbell Capital Management Inc.

Campbell Capital Management Inc. acquired a new position in shares of Aflac Incorporated (NYSE:AFL) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 500 shares of the financial services provider’s stock, valued at approximately $52,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in AFL. Whipplewood Advisors LLC acquired a new stake in shares of Aflac during the fourth quarter worth $26,000. Darwin Wealth Management LLC acquired a new stake in shares of Aflac during the third quarter worth $34,000. BankPlus Trust Department acquired a new stake in shares of Aflac during the fourth quarter worth $34,000. Raelipskie Partnership acquired a new stake in shares of Aflac during the third quarter worth $38,000. Finally, OFI Invest Asset Management acquired a new stake in shares of Aflac during the fourth quarter worth $38,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AFL has been the topic of a number of research analyst reports. BMO Capital Markets started coverage on shares of Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective on the stock. Morgan Stanley raised their target price on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. JPMorgan Chase & Co. raised their target price on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, January 7th. Evercore ISI decreased their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research report on Wednesday, December 4th. Finally, StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $103.36.

Aflac Stock Performance

Shares of AFL opened at $107.44 on Friday. The firm has a 50-day moving average of $105.37 and a 200-day moving average of $107.69. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The company has a market cap of $58.72 billion, a PE ratio of 11.19, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 55,546 shares of company stock valued at $5,863,616. Company insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.